These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18505942)

  • 1. Glucose-insulin-potassium therapy in patients with STEMI.
    Selker HP; Ingwall J; Rackley CE
    JAMA; 2008 May; 299(20):2385; author reply 2387-8. PubMed ID: 18505942
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose-insulin-potassium therapy in patients with STEMI.
    Chaudhuri A; Nesto R; Dandona P
    JAMA; 2008 May; 299(20):2386-7; author reply 2387-8. PubMed ID: 18505943
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose-insulin-potassium therapy in patients with STEMI.
    Arora RR; Katragadda S
    JAMA; 2008 May; 299(20):2386; author reply 2387-8. PubMed ID: 18505944
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
    Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
    JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Apstein CS
    JAMA; 2005 Jun; 293(21):2596-7; author reply 2598. PubMed ID: 15928276
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Dey J; Blonde L; Burshell A; Bolton P; Richard A
    JAMA; 2005 Jun; 293(21):2597-8; author reply 2598. PubMed ID: 15928277
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Cobb LA; Killip T; Lambrew CT; MacLeod BA; Rackley CE; Selker HP; Zalenski RJ
    JAMA; 2005 Jun; 293(21):2597; author reply 2598. PubMed ID: 15928278
    [No Abstract]   [Full Text] [Related]  

  • 8. [With advantage or disadvantage? The controversy on polarized fluid has come to a conclusion in the end].
    Huang J
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1801. PubMed ID: 19040011
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of blood glucose in patients with acute coronary syndromes.
    Lipska KJ; Kosiborod M
    Rev Cardiovasc Med; 2012; 13(2-3):e77-88. PubMed ID: 23160165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction.
    Zhang L; Zhang L; Li YH; Zhang HY; Chen ML; Gao MM; Hu AH; Yang HS; Yang HS
    Eur J Clin Invest; 2005 Mar; 35(3):164-70. PubMed ID: 15733070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucose-insulin-potassium solution on acute myocardial infarction outcome in patients received streptokinase according to Killip classes.
    Soltani Z; Samadikhah J; Azarfarin R; Hashemi B; Nezami N
    Anadolu Kardiyol Derg; 2010 Aug; 10(4):372-5. PubMed ID: 20693135
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction.
    Rackley CE; Russell RO; Rogers WJ; Mantle JA; McDaniel HG; Papapietro SE
    Am Heart J; 1981 Dec; 102(6 Pt 1):1038-49. PubMed ID: 7032266
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is justified the use of GIK solutions in acute myocardial infarct?].
    de Micheli A
    Arch Cardiol Mex; 2008; 78(3):243-6. PubMed ID: 18959010
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucose, insulin, and the cardiovascular system.
    Broomhead CJ; Colvin MP
    Heart; 2001 May; 85(5):495-6. PubMed ID: 11302992
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
    Mehta SR; Yusuf S; Díaz R; Zhu J; Pais P; Xavier D; Paolasso E; Ahmed R; Xie C; Kazmi K; Tai J; Orlandini A; Pogue J; Liu L;
    JAMA; 2005 Jan; 293(4):437-46. PubMed ID: 15671428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Status of glucose-insulin-potassium solutions in acute myocardial infarct].
    Artese D; Albani A; Di Nicola A
    Clin Ter; 1985 Jun; 113(6):457-65. PubMed ID: 3896620
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group.
    Díaz R; Paolasso EA; Piegas LS; Tajer CD; Moreno MG; Corvalán R; Isea JE; Romero G
    Circulation; 1998 Nov; 98(21):2227-34. PubMed ID: 9867443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-insulin-potassium for acute myocardial infarction: remarkable results from a new prospective, randomized trial.
    Apstein CS
    Circulation; 1998 Nov; 98(21):2223-6. PubMed ID: 9826307
    [No Abstract]   [Full Text] [Related]  

  • 19. Simple principles of clinical trials remain powerful.
    Califf RM
    JAMA; 2005 Jan; 293(4):489-91. PubMed ID: 15671435
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycometabolic status and acute myocardial infarction: has the time come for glucose-insulin-(potassium) therapy?
    Wong V; Cheung NW; Boyages SC
    Intern Med J; 2003; 33(9-10):443-9. PubMed ID: 14511197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.